Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 13 | 2024 | 1092 | 1.590 |
Why?
|
| PPAR gamma | 4 | 2016 | 55 | 1.430 |
Why?
|
| Receptors, Androgen | 5 | 2022 | 144 | 1.020 |
Why?
|
| Thiazolidinediones | 3 | 2011 | 49 | 0.940 |
Why?
|
| Metformin | 1 | 2022 | 75 | 0.700 |
Why?
|
| Cell Line, Tumor | 10 | 2024 | 2676 | 0.580 |
Why?
|
| Apoptosis | 9 | 2024 | 1568 | 0.510 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2022 | 968 | 0.490 |
Why?
|
| Cell Division | 7 | 2005 | 311 | 0.470 |
Why?
|
| Calcitriol | 6 | 2005 | 32 | 0.460 |
Why?
|
| Signal Transduction | 4 | 2024 | 2157 | 0.430 |
Why?
|
| RNA, Messenger | 7 | 2022 | 1271 | 0.390 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2010 | 19 | 0.390 |
Why?
|
| Androgens | 4 | 2022 | 106 | 0.380 |
Why?
|
| Chromans | 2 | 2011 | 16 | 0.380 |
Why?
|
| Cell Proliferation | 6 | 2024 | 1455 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2011 | 63 | 0.340 |
Why?
|
| Transforming Growth Factor beta | 5 | 2022 | 216 | 0.320 |
Why?
|
| Cell Cycle | 4 | 2024 | 346 | 0.320 |
Why?
|
| Receptors, Calcitriol | 3 | 2005 | 69 | 0.280 |
Why?
|
| Male | 18 | 2024 | 23409 | 0.280 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 241 | 0.250 |
Why?
|
| Prostate | 5 | 2004 | 155 | 0.240 |
Why?
|
| Serpins | 2 | 2003 | 27 | 0.240 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 13 | 0.230 |
Why?
|
| Calcium Channel Agonists | 1 | 2005 | 3 | 0.230 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2005 | 4 | 0.230 |
Why?
|
| Vitamin D | 2 | 2005 | 196 | 0.230 |
Why?
|
| Humans | 20 | 2025 | 43102 | 0.230 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 27 | 0.230 |
Why?
|
| Dihydrotestosterone | 3 | 2016 | 28 | 0.210 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 2024 | 2 | 0.210 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 12 | 0.210 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 1019 | 0.210 |
Why?
|
| Glucose | 2 | 2022 | 244 | 0.210 |
Why?
|
| Capacity Building | 1 | 2025 | 99 | 0.210 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2024 | 23 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 220 | 0.200 |
Why?
|
| Castration | 1 | 2022 | 34 | 0.190 |
Why?
|
| Genomics | 1 | 2025 | 293 | 0.190 |
Why?
|
| Annexin A6 | 1 | 2022 | 17 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 299 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2023 | 226 | 0.180 |
Why?
|
| Cell Differentiation | 2 | 2003 | 638 | 0.160 |
Why?
|
| Epithelial Cells | 2 | 2003 | 434 | 0.160 |
Why?
|
| Cyclin D1 | 2 | 2010 | 44 | 0.160 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 436 | 0.130 |
Why?
|
| Retinoids | 1 | 1997 | 25 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 189 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 223 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 1997 | 291 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 592 | 0.100 |
Why?
|
| Gene Expression | 2 | 2010 | 701 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2005 | 536 | 0.090 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 20 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2009 | 56 | 0.080 |
Why?
|
| Transfection | 2 | 2010 | 532 | 0.080 |
Why?
|
| Androgen-Binding Protein | 1 | 2010 | 2 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2010 | 148 | 0.080 |
Why?
|
| Prostate-Specific Antigen | 1 | 2010 | 147 | 0.080 |
Why?
|
| HIV Infections | 1 | 2023 | 2586 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 184 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2011 | 986 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 4 | 2004 | 508 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2003 | 1070 | 0.060 |
Why?
|
| cdc25 Phosphatases | 1 | 2005 | 5 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2005 | 23 | 0.060 |
Why?
|
| Acid Phosphatase | 1 | 2005 | 23 | 0.060 |
Why?
|
| Mutation | 1 | 2010 | 1177 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2005 | 456 | 0.060 |
Why?
|
| National Human Genome Research Institute (U.S.) | 1 | 2025 | 5 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2003 | 97 | 0.060 |
Why?
|
| Animals | 8 | 2004 | 16992 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2005 | 77 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2005 | 109 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2025 | 120 | 0.050 |
Why?
|
| Growth Substances | 1 | 2004 | 16 | 0.050 |
Why?
|
| Tennessee | 1 | 2023 | 93 | 0.050 |
Why?
|
| Phorbol Esters | 1 | 2003 | 8 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 26 | 0.050 |
Why?
|
| G1 Phase | 1 | 2003 | 31 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2003 | 55 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 13 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 81 | 0.050 |
Why?
|
| Rats | 4 | 2003 | 3735 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2024 | 333 | 0.040 |
Why?
|
| Schools | 1 | 2023 | 283 | 0.040 |
Why?
|
| Disease Progression | 1 | 2024 | 667 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2024 | 273 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 218 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 655 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1999 | 26 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 532 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1999 | 78 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2003 | 1621 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1999 | 165 | 0.040 |
Why?
|
| Students | 1 | 2023 | 626 | 0.030 |
Why?
|
| Benzoates | 1 | 1997 | 17 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1997 | 27 | 0.030 |
Why?
|
| Progesterone | 1 | 1997 | 121 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 1997 | 93 | 0.030 |
Why?
|
| Mice | 4 | 2004 | 6644 | 0.030 |
Why?
|
| Risk Factors | 1 | 2004 | 3994 | 0.030 |
Why?
|
| United States | 1 | 2025 | 5205 | 0.030 |
Why?
|
| Cell Line | 3 | 2002 | 1410 | 0.020 |
Why?
|
| Mice, Nude | 2 | 2000 | 408 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2004 | 2 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2004 | 22 | 0.010 |
Why?
|
| Thymidine | 1 | 2004 | 15 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2004 | 12 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 68 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2004 | 67 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 148 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 462 | 0.010 |
Why?
|
| Cyclins | 1 | 2003 | 34 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2003 | 34 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2004 | 321 | 0.010 |
Why?
|
| Tretinoin | 1 | 2003 | 50 | 0.010 |
Why?
|
| Fibrinolysin | 1 | 2002 | 9 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 195 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 386 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 526 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 152 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 267 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 314 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1124 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 652 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 98 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 1180 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 1542 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2002 | 876 | 0.010 |
Why?
|
| Finasteride | 1 | 1998 | 4 | 0.010 |
Why?
|
| Flutamide | 1 | 1998 | 7 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 1998 | 29 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 704 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 518 | 0.010 |
Why?
|
| Antibodies | 1 | 1998 | 144 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 491 | 0.010 |
Why?
|
| Testosterone | 1 | 1998 | 211 | 0.010 |
Why?
|